Last reviewed · How we verify
NCT06668675: HRIDAYA
Digital Cardiovascular Health Promotion Among School-going Adolescents in Nepal
NA trial testing A serious game known as the 'Happy Heart' will be used as the intervention. in Heart Disease in 345 participants. Completed in 10 September 2023.
10 September 2023
Quick facts
| Lead sponsor | Kathmandu Medical College and Teaching Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 345 |
| Start date | 2 July 2023 |
| Primary completion | 10 September 2023 |
| Estimated completion | 10 September 2023 |
| Sites | 1 location across Nepal |
Drugs / interventions tested
- A serious game known as the 'Happy Heart' will be used as the intervention.
Conditions studied
- Heart Disease — all drugs for Heart Disease →
Sponsor
Kathmandu Medical College and Teaching Hospital
Who can join
Adults 13 to 15, any sex, with Heart Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this HRIDAYA project is to see if a digital mobile game can improve knowledge about heart disease among school-going adolescents. The researchers will divide adolescents of public and private schools into two groups. Each group will contain adolescents from both the school types. Knowledge, attitude and practice (KAP) of adolescents will be tested before intervention. One group will receive a mobile game and the other will not receive the game. After two weeks of game play, the KAP of the adolescents will be tested again. The changes in KAP before and after playing the game in the two groups will be compared. The participants will need to: * Give pretest of KAP regarding CVD * Download the game in their mobile devices. * Install the game * Play the game for 2 weeks * Give post test of KAP regarding CVD
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06668675
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Heart Disease
Currently open trials in the same condition.
- NCT07380243 — Pathways to Prevention Food-is-Medicine Trial · NA · recruiting
- NCT07126587 — Healthy Living Anson Study · NA · recruiting
- NCT06927739 — Focused Orticumab Research for Treating Inflammation in Coronary Arteries · Phase 2 · recruiting
- NCT06420960 — Diagnostic Efficacy of Connected WAtch ECG Versus External Holter ECG · NA · recruiting
- NCT06896318 — Virtual Reality-Supported Cardiac Rehabilitation: Psychological, Functional, and Physiological Perspectives · NA · active not recruiting
Other Kathmandu Medical College and Teaching Hospital trials
Trials by the same sponsor.
- NCT06949384 — Self-Esteem Status Among Medical Students: A Descriptive Study · completed
- NCT04742205 — ITCH Trial: Protocol for a Randomized, Double Blind Placebo-controlled Trial · Phase 2, PHASE3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06668675 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kathmandu Medical College and Teaching Hospital
- Last refreshed: 31 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06668675.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing